Can we predict successful cervical ripening with prostaglandin E2 vaginal inserts?

Area of Science:

• Obstetrics and Gynecology
• Reproductive Medicine
• Maternal-Fetal Medicine

Background:

• Previous research on prostaglandin E2 (PGE2) cervical ripening predictors primarily used vaginal tablets or gels.
• Limited data exists on predictors for slow-release PGE2 vaginal insert efficacy.
• Understanding these predictors is crucial for optimizing labor induction protocols.

Purpose of the Study:

• To evaluate the effectiveness of slow-release PGE2 vaginal inserts for cervical ripening.
• To identify maternal and obstetrical predictors of successful cervical ripening using this method.
• To characterize the response to slow-release PGE2 vaginal inserts in labor induction.

Main Methods:

• Retrospective cohort study (2013-2015) at a single center.
• Analyzed maternal characteristics at admission to predict cervical ripening success or failure.
• Defined failure as a Bishop's score <7 after 24 hours or Cesarean delivery for arrest of dilatation at ≤5 cm cervical dilation.

Main Results:

• Out of 986 women meeting criteria, 78.56% achieved successful cervical ripening.
• Success was associated with higher gestational age (OR 1.29) and greater cervical dilation at admission (OR 4.58).
• Nulliparity was negatively associated with successful ripening (OR 0.42). A prediction model achieved an AUC of 0.792.

Conclusions:

• Parity, cervical dilation at admission, and gestational age are significant predictors of successful cervical ripening with PGE2 vaginal inserts.
• These basic parameters can inform clinical decisions regarding labor induction.
• The findings support the use of these factors in predicting the success of slow-release PGE2 cervical ripening.